- Home
- CLLS vs HCKT Comparison
CLLS vs HCKT Comparison
Compare CLLS & HCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLLS | HCKT |
|---|---|---|
| Founded | 1999 | 1991 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 374.2M | 392.0M |
| IPO Year | 2014 | 1998 |
Fundamental Metrics
Financial Performance| Metric | CLLS | HCKT |
|---|---|---|
| Price | $3.80 | $14.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | $8.50 | ★ $17.00 |
| AVG Volume (30 Days) | 35.0K | ★ 313.8K |
| Earning Date | 01-01-0001 | 05-19-2026 |
| Dividend Yield | N/A | ★ 3.46% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.46 |
| Revenue | N/A | ★ $285,862,000.00 |
| Revenue This Year | $32.58 | $2.55 |
| Revenue Next Year | $20.68 | $5.07 |
| P/E Ratio | ★ N/A | $30.27 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.10 | $12.76 |
| 52 Week High | $5.48 | $29.65 |
Technical Indicators
Market Signals| Indicator | CLLS | HCKT |
|---|---|---|
| Relative Strength Index (RSI) | 45.66 | 38.31 |
| Support Level | $3.41 | $12.76 |
| Resistance Level | $4.46 | $21.13 |
| Average True Range (ATR) | 0.17 | 0.68 |
| MACD | 0.01 | 0.15 |
| Stochastic Oscillator | 40.00 | 52.61 |
Price Performance
Historical ComparisonAbout CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About HCKT Hackett Group Inc (The).
The Hackett Group Inc is an IP platform-based Generative Artificial Intelligence (Gen AI) strategic consulting and executive advisory digital transformation firm. The Hackett Group provides dedicated expertise in Gen AI-enabled enterprise transformation services across the front, mid and back office areas, including its highly recognized Oracle, SAP, OneStream and Coupa implementation offerings. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.